Drug-Access Pipeline in Portugal Stalls at 650 Days Between EU Authorisation and SNS Funding Decision — Pharma Takes 272 Days to Submit, Infarmed Takes 332 to Decide, Negotiation Adds 319 More
Lusa lands the average gap between an EU market authorisation and a Portuguese SNS-funding decision at 650 days — pharma takes 272 to submit, Infarmed 332 to decide, negotiation 319 more. Of 188 dossiers between 2020 and 2025, 102 closed and 77 medicines funded.